After E 2 treatment the ED 50 response in Tg ( / ) rats was no different from Tg ( 0 ) rats. However, the associated with a reduction in cardiovascular maximum vasodilation elicited by Ach was events in women, but the mechanisms for this attenuated in Tg ( / ) as compared with Tg ( 0 ) rats. protection are unclear, especially in hypertensive
MATERIALS AND METHODS
pidemiological studies indicate a relatively lower incidence of cardiovascular events in premenopausal women as compared with age-matched men. 1, 2 This difference lessens with the onset of menopause and, within a decade, the Surgical Procedures Following approval by the Instinumber of cardiovascular events in postmenopausal tutional Animal Care and Use Committee, thirty 12 week women is as high or higher than in men. 3 While it is old, heterozygous female Tg(0) and hypertensive accepted that estrogen replacement therapy is associ-Tg(/) rats (body weight: 220 to 250 g) from the Hyperated with a 50% reduction in the risk of cardiovascular tension Center Transgenic Animal Research Colony of disease in postmenopausal women, 4 ,5 the mechanisms the Bowman Gray School of Medicine were anesthetized affording this cardiac and vascular protection remain with ketamine (30 mg/kg, intramuscularly) and xylazpoorly understood. Differences in lipoprotein metab-ine (5 mg/kg, intramuscularly ) and bilaterally ovariecolism, insulin levels, fibrinolytic activity, and blood tomized. The animals were implanted subcutaneously pressure have been advanced as possible explanations with pellets containing either 17b-estradiol (E 2 ) (1.5 for estrogen-induced cardioprotection. 6 -8 However, mg/rat, for 3 week release) or placebo (Innovative Rethese mechanisms do not provide a sufficient explana-search of America, Toledo, OH) ; animals were randomtion for the beneficial effects of estrogen on the cardio-ized into four groups: ovariectomized Tg(/)/placebo, vascular system. ovariectomized Tg(/)/E 2 , ovariectomized Tg(0)/plaRecent studies have suggested that estrogen-in-cebo, and ovariectomized Tg(0)/E 2 . After recovery, duced cardioprotection may be mediated by an in-rats were allowed free access to water and fed normal crease in the production of vascular nitric oxide ( NO ) . powder chow providing 17 mEq of Na / and 28 mEq of Hayashi et al 9 demonstrated that the basal release of K / per 100 g of solid weight (Rodent Laboratory Chow NO from aortic rings of female rabbits is greater than 5001, Purina Mills Inc., Richmond, IN). The animals males and correlates with circulating estradiol levels. were housed individually in plastic cages in a room 17b-Estradiol increases the expression of constitutive maintained at 22ЊC and lighted for 12 h. NO synthase in tissues in vivo and cultured endothelial cells in vitro. 10 -13 Estrogen treatment improves en-Experimental Protocols At the end of the 3 week period of hormone replacement, rats were again anesthedothelium-dependent vasodilation of coronary and peripheral arteries to acetylcholine while it also in-tized with ketamine and xylazine, and a polyethylene catheter ( PE-50, Clay Adams, Becton-Dickinson, Frankcreases circulating NO ( nitrite / nitrate ) levels in postmenopausal women and surgically ovariectomized lin Lakes, NJ ) was implanted into the abdominal aorta via the right femoral artery. Another plastic catheter monkeys. 14 -17 In animal models of hypertension chronic estrogen was placed into the inferior vena cava through the right femoral vein. The free end of both catheters was tuntreatment partially reverses the diminished endothelium-dependent relaxation 18, 19 and attenuates the neled to the back of neck as described previously. 24 All procedures were performed under sterile condition and magnitude of the blood pressure rise in spontaneously hypertensive rats ( SHR ) . 20, 21 In keeping with these followed by an injection of a prophylactic dose of antibiotics ( Penicillin G, 30,000 U intramuscularly ) . The findings we have demonstrated an amplification of nitric oxide dependent vasodilation in transgenic hy-animals were allowed 2 days of recovery. The arterial catheter was connected to a solid strain-gauge micropertensive rats harboring the mouse Ren-2 gene [m( Ren2 ) 27 ]. 22 Moreover, a pronounced sexual di-transducer ( MP-150, Micron Instruments Inc., Los Angeles, CA ) . Blood pressure was determined by a morphism of blood pressure can be demonstrated between age-matched male and female transgenic rats.
23
PC-based data acquisition program developed in our laboratory, and the arterial pressure waveform was also With this in mind, we have evaluated the effects of chronic 17b-estradiol treatment on blood pressure displayed in a polygraph ( Model 7, Grass Instruments Inc., Quincy, MA ) . 25 After a 1-h stabilization period, and vascular endothelial function of age-matched female transgenic positive [ Tg ( / ) ] hypertensive rats as dose-dependent phasic pressor responses to intravenous injections of phenylephrine ( doses: 2, 5, 10 mg) were obtained in conscious, freely moving animals. On the day following blood pressure measurements, removed and dissected free of connective tissues. The prepared in distilled water and stored at 020ЊC in stock solution. A23187 was dissolved in dimethyl sulfoxide vessels were cut into 3 mm rings and mounted in organ chambers filled with modified Krebs-Henseleit buffer and indomethacin was dissolved in 0.2 mol / L Na 2 CO 3 in stock and diluted in Krebs buffer. Drug concentra-(composition in mmol/L: NaCl 118.3, KCl 4.7, CaCl 2 2.5, MgSO 4 1.2, KH 2 PO 4 1.2, NaHCO 3 25, CaNaEDTA tions were expressed as final molar ( mol/L) concentration in organ chamber. 0.026, and glucose 11). The solution was aerated with 95% O 2 and 5% CO 2 at 37ЊC (pH 7.4) and contained Statistical Analysis Vascular relaxation was ex-10 mmol/L indomethacin to prevent the production of pressed as percentage ( % ) of isometric tension of rings vasoactive prostaglandins throughout the experiment. In preconstricted with 10 07 mol / L PE and constriction some rings, the endothelium was denuded by gentle was normalized as percentage ( % ) of 80 mmol / L KClmechanical rubbing with a stainless steel wire. The iso-induced maximal contraction. The concentration of metric tension was measured continuously by using a drugs inducing 50% ( ED 50 ) of the maximal relaxation polygraph (Model 7, Grass Instrument Inc., Quincy, was calculated using a nonlinear regression method MA). Basic tension was set at 2 g after a 60 min equilibra-( Sigmoid curve fitting program, PRISM, San Diego, tion period. In preliminary experiments, we established CA ) . All values are mean { SEM ( standard error of that 2 g of tension was optimal for both normotensive mean ) . One way analysis of variance ( ANOVA ) foland hypertensive rat aorta rings after repeated exposure lowed by Neuman-Keul's test for multiple comparisons to 40 mmol/L KCl. Endothelial integrity was tested us-was used for statistical comparison. In addition, the ing 10 06 mol/L acetylcholine (Ach) in rings precon-Student's t test for unpaired observation for blood presstricted with 10 06 mol/L phenylephrine (PE). The pres-sure, heart rate, and 17b-estradiol levels was used for ence of a functional endothelium was associated with statistical analysis. A P value of õ .05 was considered more than 60% relaxation to Ach, whereas the absence of statistically significant. relaxation using the same dose of Ach indicated effective removal of the endothelium. The endothelium-depen-RESULTS dent relaxation curves of Ach ( 10 010 to 10 04 mol/L), The baseline levels of mean blood pressure and heart and the calcium ionophore, A23187(10 010 to 10 05 mol/ rate of conscious freely moving Tg ( / ) and Tg(0) rats L) were obtained in intact rings preconstricted with 10 07 at the end of 3 weeks of estrogen replacement therapy mol/L PE. The contribution of endothelium to the dose-or placebo are summarized in Table 1 . Mean blood dependent vasodilation was investigated in the rings pressure of ovariectomized female Tg ( / ) rats was with denuded endothelium or pretreated with NO syn-higher than that recorded in normotensive controls thase inhibitor L-nitro-arginine methyl ester (L-NAME, regardless of whether animals were exposed to estro-10 04 mol/L) for 30 min. To determine whether estrogen gen replacement. Chronic 17b-estradiol treatment replacement modulates the vasoactivity of vascular lowered mean blood pressure in normotensive rats smooth muscle cells in both normotensive and hyperten-and attenuated the magnitude of the blood pressure sive rat aorta, relaxation-response curves to sodium ni-rise in Tg ( / ) rats. Heart rate was not changed with troprusside (SNP, 10 010 to 10 07 mol/L) were also evalu-estrogen replacement therapy. Plasma 17b-estradiol ated in aortic rings preconstricted with PE (10 07 mol/ levels were 214 { 33 pg /mL and 166 { 20 pg /mL L). An indirect estimate of basal release of NO from for E 2 treated Tg ( / ) and Tg ( 0 ) groups, respectively, intact vascular rings was evaluated, as previously de-and less than 15 pg /mL for both placebo groups. scribed by Frew et al. 26 Vessels were mildly constricted Estrogen Attenuates Phenylephrine Mediated Vascuwith PE (3 1 10 08 mol/L) and then exposed to the lar Constriction Chronic 17b-estradiol treatment sig-NO synthase inhibitor N G -monomethyl-L-arginine (Lnificantly attenuated the pressor responses to intrave-NMMA, 10 04 mol/L), which was demonstrated prenous injection of PE in Tg ( /) hypertensive ( P õ .01 ) viously to be selective for blocking basal NO release in and Tg ( 0) normotensive rats ( P õ .05 ) ( Figure 1A and the rat aorta. 26 Denuded rings and those pretreated with 1B ) in a dose-dependent manner, except at the highest L-NAME (10 04 mol/L, 20 min) were preconstricted with PE (10 08 mol/L) to achieve a similar degree of vascular tone, because removal of endothelium and blockade of NO synthase with L-NAME enhance the dose of PE in normotensive rats. Placebo treated Tg ( /) lium and pretreatment with the NO synthase inhibitor L-NAME ( 10 04 mol/L) abolished the endothelium-derats showed markedly higher pressor responses to intravenous injections of PE as compared with similarly pendent vasodilation of all four groups of animals ( six to eight rings from five to seven rats, data not shown ) . treated Tg ( 0) rats ( P õ .01 ) . The hyperresponses to PE in Tg ( /) rats were abolished after estrogen treat-There were no differences in the vasodilator responses elicited by the NO donor, sodium nitroprusside, bement, as there was no significant difference in the PE responses between estrogen treated Tg ( /) and Tg ( 0) tween Tg ( /) hypertensive and normotensive animals regardless of the presence of estrogen ( Figure 4 ) . animals.
Estrogen Treatment Modulates Endothelium Depen-Effects of Estrogen Treatment on Basal NO Activity in Vascular Rings
As an indirect measurement of dent and Independent Vasodilation The Ach-induced endothelium-dependent vascular relaxation in basal NO release, mildly preconstricted aortic rings were exposed to the NO synthase inhibitor L-NMMA. thoracic aortic rings preconstricted with 10 07 mol/L PE was less potent in Tg (/ ) as compared with normo-In the absence of estrogen, the increase in contraction following L-NMMA was significantly less in Tg ( /) as tensive rats ( ED 50 23.8 { 6.5 v 55.5 { 11.7 nmol / L, P õ .05, Tg ( 0) v Tg ( /)). Estrogen replacement signifi-compared with normotensive, placebo-treated animals (F Å 10, P õ .05, ANOVA, Tg ( /)/placebo v Tg ( 0)/ cantly enhanced Ach-induced relaxation of both hypertensive and normotensive rats ( Figure 2 ) . There was a placebo ) ( Figure 5 ) . Chronic estrogen treatment resulted in a significant enhancement of the contractions leftward shift of the ED 50 5.5-fold in Tg ( /) and 4.5-fold in Tg (0 ) rats ( Table 2 ) . After E 2 treatment, there of aortic rings exposed to L-NMMA, suggesting that E 2 treatment increases the basal release of NO from both was no significant difference in the ED 50 values of Tg ( /) and Tg ( 0) rats. In addition, E 2 replacement en-hypertensive and normotensive animals. There was no difference in the maximal contraction reached between hanced the maximum vasodilation elicited by Ach in both Tg ( /) and Tg ( 0) rats. The maximum responses the Tg ( /) and Tg ( 0) estrogen-treated rats. Either removal of the endothelium or pretreatment with Lto Ach were significantly less in Tg (/ ) hypertensive rats as compared to similarly treated normotensive con-NAME ( 10 04 mol/L) abolished the responses ( six to eight rings from five to seven rats in each group; data trols ( Table 2 ) .
The non -receptor-mediated, endothelium-depen-not shown ) . dent vasodilation induced by the calcium ionophore, DISCUSSION A23187 was less potent in Tg ( /) as compared with Tg ( 0) rats. E 2 treatment increased the A23187-induced The present study demonstrates that chronic estrogen replacement was effective in reducing blood pressure vasodilation only in Tg ( /) rats. The ED 50 of Tg ( /)/ E 2 was shifted leftward by sixfold, whereas there was in both normotensive and hypertensive female rats.
Without estrogen replacement therapy, hypertensive no difference in the ED 50 of Tg ( 0) animals treated with either placebo or E 2 ( Figure 3) NO and reduced contributions of receptor-and non -tion, a correlation has been reported between plasma levels of estradiol achieved and cardiovascular outreceptor-mediated, endothelium-dependent relaxation as compared with normotensive controls. Our comes. 9, 15, 31 In our study the concentrations of 17b-estradiol averaged 190 { 20 pg /mL, a value that apstudy shows for the first time that endothelial function of both normotensive and hypertensive animals can proximates those found during estrus ( 100 pg /mL ) in the rat 32 and were equivalent to those reached during be enhanced with chronic estrogen treatment and that in hypertensive female Tg ( / ) animals endothelial replacement therapy in postmenopausal subjects. 31, 33 These levels of estrogen were associated with a similar dysfunction can be significantly improved by estrogen replacement.
magnitude of reduction of blood pressure in hypertensive and normotensive animals ( 14 v 11 mm Hg ) . A positive feature of these studies was the use of ovariectomized transgenic female rats to unravel the In hypertensive rats, this change resulted in an attenuation of the blood pressure rise. It should be pointed effects of hormone replacement therapy on endothelial and vascular smooth muscle function. Surgical out, however, that the reduction in blood pressure in E 2 -treated Tg(/) animals may be sufficient to reduce ovariectomy has been used frequently as a experimental model of postmenopause to study hormone re-the risk of stroke and other cardiovascular complications that are of more frequent occurrence with inplacement on the progression of coronary artery atherosclerosis, 17 on basal blood pressure and hemody-creased hypertension. 34 -36 Since the earlier report by Mullins et al., 37 several namics, 27 and on lipid metabolism. 7 The effects of estrogen replacement therapy on blood pressure have other studies from our laboratory 22, 24, 38 and those of others 39 -41 have described the hemodynamic, strucremained controversial, with published studies reporting either no effect 28, 29 or a decrease in blood pres-tural, and hormonal characteristics of this animal model of high blood pressure. We also showed that sure.
27,30 These discrepancies may in part reflect the dose of estrogen used or the strain / species of subjects in response to acute blockade of nitric oxide synthase, transgenic female heterozygous rats showed an enstudied. In most studies plasma levels of estradiol were not measured, leaving unanswered the question hanced compensatory activity of endothelium-derived relaxing factor, nitric oxide. 22 This would sugof whether the effects are of physiological or pharmacological significance. In keeping with this interpreta-gest that the hypertension resulting from overex- pression of the renin gene activates a buffering who showed that a greater basal capacity to release NO was accompanied with no change in acetylchoresponse from the vascular endothelium that is significantly greater in Tg hypertensive as compared to line-induced relaxation. In adult animals the basal capacity to release NO from the coronary arteries was normotensive animals. In the present studies, however, a diminished endothelium contribution of both significantly smaller in transgenic animals as compared to normotensive controls, a finding that is in basal and stimulated nitric oxide was found in aortic rings from Tg ( / ) rats, as measured by L-NMMA-agreement with the responses found in thoracic vessels taken from adult animals in our study. While difinduced constriction and Ach-induced relaxation of aortic rings. Differences in the whole animal and the ferent mechanisms may be activated by endogenous inhibition of NO, the current experiments and those in vitro responses after nitric oxide blockade could be the resultant of NO's effects in different vascular beds, previously published 22 demonstrate a consistent effect of estrogen replacement therapy in potentiating the compounding influence of flow and pressure on release of nitric oxide in the whole animal, and actions the vasodilator actions of NO, both in vivo 22 and in isolated blood vessels. within the central and peripheral nervous system. A selective defect in the coronary endothelium of young Nitric oxide, as a potent endothelium-derived vasodilator, has a strong impact on the regulation of blood transgenic rats was demonstrated by Tschudi et al, pressure and vascular tone. 43, 44 Abnormalities in en-dent vasorelaxation is not likely to be mediated by endothelium-derived hyperpolarizing factor ( EDHF ) , dothelial production of NO occur in atherosclerosis and hypertension. 45 Huang et al 46 demonstrated that as NO synthase inhibition completely abolished the augmented response. 47 In addition, because all vessels mice lacking the gene for endothelial NO synthase develop hypertension. In these animals Ach-induced in this study were treated with indomethacin, a participation of prostaglandins was excluded. The contribuendothelium-dependent vasodilation was absent. In the present study, the effects of estrogen on endothe-tion of non -receptor-mediated endothelium dependent relaxation, by the calcium ionophore, A23187, lial production of NO were measured by assessing endothelium-dependent vasodilation by Ach in the was found to be influenced by estrogen only in the Tg ( / ) hypertensive rats. The lack of effect on the thoracic aorta of normotensive and transgenic rats. The hypertensive animals when left untreated, how-non -receptor-mediated relaxation in normotensive animals is in agreement with previous studies by Gisever, showed a lesser degree of maximal dilatory capacity to Ach, a reduced potency to Ach, and less clard et al. 48 Estrogen may act at a post-receptor site, imparting additional improvement of endothelial ability to release NO, when compared to untreated normotensive animals. The ED 50 to Ach, the maximal function in transgenic hypertensive animals. Because the relaxation sensitivity to sodium nitroprusside was dilatory response, and the basal release of NO were markedly enhanced by chronic treatment with estro-unchanged with either estrogen treatment or hypertension, our results would indicate that the response gen in both normotensive and hypertensive animals. The fact that the response to L-NMMA was increased of the vascular smooth muscle cells to EDRF / NO is not influenced by estrogen or exposure to high blood to a similar extent in Tg ( / ) rats as compared with Tg ( 0 ) rats in the presence of estrogen suggests a pressure.
Another observation made in these studies was that greater enhancement of basal production of NO in the Tg ( / ) rats, in light of their lower basal level of NO estrogen enhances the basal release of NO from the endothelium of TG ( / ) and Tg ( 0 ) rats. As an indirect without estrogen. These findings are in agreement with previous studies, which showed that estrogen measure of basal release of NO, the time-dependent contractions in vessels treated with the NOS inhibitor, increases the expression of endothelial NO synthase.
11,13 Our studies further illustrate that a number L-NMMA, have been used as an estimate of basal release of NO in arteries from rats, 26 rabbits, 9 pigs, 49 of abnormalities in the hypertensive rats can not be entirely corrected by estrogen. The maximal dilatory and coronary arteries of transgenic rats. 42 In comparison to vessels from Tg ( 0 ) rats treated with placebo, response to Ach in the Tg ( / ) rats, although enhanced by estrogen, was not entirely normalized when com-hypertensive rats without estrogen have a reduced endothelium dependent contraction, indicative of a pared to estrogen-treated, normotensive rats. On the other hand, use of the calcium ionophore uncovered lower basal release rate of NO and suggesting that hypertension itself impairs the basal release of NO a deficiency in untreated, hypertensive rats that was corrected in the presence of estrogen to values no dif-from thoracic aorta endothelium. Estrogen markedly augmented the constriction of aortic rings to NO synferent than the responses in normotensive control.
The action of estrogen on the endothelium-depen-thase inhibitors in both Tg ( / ) and Tg ( 0 ) rats, reach- 
